Lentiviral vectors can be used to genetically modify a broad range of cells. Hematopoietic stem cells (HSCs) are particularly suitable for lentiviral gene augmentation, because these cells can be enriched with relative ease from mouse bone marrow and human hematopoietic sources, and in principle require relatively limited cell numbers to completely reconstitute the hematopoietic system in vivo. Furthermore, lentiviral vectors are very efficient if pseudotyped with broad tropism envelope proteins. This chapter focuses on gene modification by the use of self-inactivating third-generation human immunodeficiency virus-derived lentiviral vectors for ex vivo HSC modification for both mouse and human application. © 2014 Springer Science+Business Media New York.
CITATION STYLE
Van Til, N. P., & Wagemaker, G. (2014). Lentiviral gene transduction of mouse and human hematopoietic stem cells. Methods in Molecular Biology, 1185, 311–319. https://doi.org/10.1007/978-1-4939-1133-2_21
Mendeley helps you to discover research relevant for your work.